Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Silence Therapeutics (SLN) Other Operating Expenses (2024 - 2025)

Historic Other Operating Expenses for Silence Therapeutics (SLN) over the last 1 years, with Q2 2025 value amounting to -$20.7 million.

  • Silence Therapeutics' Other Operating Expenses changed N/A to -$20.7 million in Q2 2025 from the same period last year, while for Sep 2025 it was -$49.1 million, marking a year-over-year change of. This contributed to the annual value of -$113.6 million for FY2024, which is N/A changed from last year.
  • According to the latest figures from Q2 2025, Silence Therapeutics' Other Operating Expenses is -$20.7 million.
  • Silence Therapeutics' Other Operating Expenses' 5-year high stood at -$20.7 million during Q2 2025, with a 5-year trough of -$28.4 million in Q1 2025.